Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by allinenergy2on Aug 13, 2015 3:37pm

109 Views

Post# 24016039

RE:Dang. Didn't mean to tank it.

You didn't tank it CasusFortuitus. You're obviously not good at what you think you do.

If you were an actual investor/trader, you would see that Anonymous has been setting this up for a bit now, hence that's why I believe we'll get a cheap financing at 10 cents.

The only thing you're good at is being transparent.

I can see right through your malicous intent to misinform for material gain.

If you were intent on voicing your opinion that ATB-346 was in fact a poison, you wouldn't think twice about ever buying it's stock.

Being the LIAR you truly are, you are thinking of buying a lottery ticket under 10 cents, which means you aren't convinced it is poison unless you can get it cheap. Good luck with your agenda.

Bullboard Posts

Eminent acquires promising Nevada gold project